Live Hepatocellular Carcinoma News with Latest Updates

Live hepatocellular carcinoma news and developments with the latest updates. Check out current hepatocellular carcinoma news stories and find out what happened, what is going on with hepatocellular carcinoma. Recent news updates about hepatocellular carcinoma
Imfinzi approved in China for treatment of extensive-stage small cell lung cancer
Study Sheds Light on Precise Personalized Hepatocellular Carcinoma Medicine
UWA awarded $6 million for groundbreaking medical research
Acta Pharmaceutica Sinica B Volume 11, Issue 6 publishes
Drinking any type of coffee associated with reduced risk of chronic liver disease
Call to reduce rising liver cancer toll
MD Anderson research highlights for June 16, 2021
SLAS Technology June special issue on 3D cell culture
Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years
Diet plays critical role in NASH progressing to liver cancer in mouse model
HKUMed researchers unveil a novel molecular mechanism underlying liver cancer drug resistance and tumour recurrence
Penn Medicine Study Suggests Long-term Suppression of Hepatitis B
Oregon State researchers discover new class of cancer fighting compounds
Researchers discover new class of cancer fighting compounds
Imfinzi and tremelimumab with chemotherapy demonstrated overall survival benefit
High rates of hepatitis C and HIV coinfection among key populations
Increased risk of liver cancer in patients with non-alcoholic fatty liver
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target
MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors
Early Access continues during coronavirus pandemic
Gene discovery suggests new treatment approach for liver cancer
Liver Cancer Tumors Appear to Be Resistant to Immunotherapy
Study in ‘Nature’ concludes immunotherapy is less efficient in non-viral liver cancer
ZJU scientists report advances in hepatocellular carcinoma
Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells
New funding to support innovative medical research
Spearheading global fight against cancer with proton therapy 26 October
New medicines for Australians with multiple sclerosis, lymphoma, carcinoma and reproductive cancers
Even mild fatty liver disease is linked to increased mortality
Investment in liver cancer medicines matched with prevention are changing Australian lives
Budget 2020-21: Record health and aged care investment under Australia’s COVID-19 pandemic plan
Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease
$24 million in CPRIT funding awarded to MD Anderson and related research
Sweet way to 3D-print blood vessels
Laser-welded sugar: Sweet way to 3D-print blood vessels
New AGA guidance addresses cancer screening in NAFLD patients
More than $47 million awarded to Monash University for vital medical research
New Liver Cancer Research Targets Non-Cancer Cells to Blunt Tumor Growth
Liver cancer: awareness of hepatitis D must be raised
New treatment extends lives of people with most common type of liver cancer
Low-dose aspirin linked to reduced liver cancer risk
Researchers find implication of a new protein in liver cancer